ruthenium has been researched along with propidium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, R; Glover, C; Guo, S; Guo, Y; Liu, D; Roebuck, D; Song, L; Sreedharan, S; Thomas, JA; Yang, M; Yang, Z; Zhou, D | 1 |
| He, RJ; Huang, GB; Huang, RZ; Jiang, H; Liang, GB; Lin, CY; Ma, XL; Wei, JH; Zhang, Y | 1 |
2 other study(ies) available for ruthenium and propidium
| Article | Year |
|---|---|
Terminal PEGylated DNA-Gold Nanoparticle Conjugates Offering High Resistance to Nuclease Degradation and Efficient Intracellular Delivery of DNA Binding Agents.
Topics: Antibiotics, Antineoplastic; Cell Survival; Coordination Complexes; Deoxyribonuclease I; DNA; Doxorubicin; Drug Carriers; Dynamic Light Scattering; Gold; HeLa Cells; Humans; Intercalating Agents; Metal Nanoparticles; Microscopy, Confocal; Polyethylene Glycols; Propidium; Ruthenium | 2015 |
Ursolic acid-piperazine-dithiocarbamate ruthenium(II) polypyridyl complexes induced necroptosis in MGC-803 cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cisplatin; Clathrin; Coordination Complexes; Humans; Mice; Necroptosis; Oleanolic Acid; Piperazine; Propidium; Ruthenium; Ursolic Acid | 2022 |